Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lilly's Olumiant Is First Drug FDA Approved For Alopecia Areata
Jun 13 2022
•
By
Jessica Merrill
Lilly is the first to market with a drug for alopecia areata • Source: Shutterstock
More from New Products
More from Scrip